Annual Working Capital
$499.51 M
-$23.27 M-4.45%
December 31, 2024
Summary
- As of March 5, 2025, SNDX annual working capital is $499.51 million, with the most recent change of -$23.27 million (-4.45%) on December 31, 2024.
- During the last 3 years, SNDX annual working capital has risen by +$71.80 million (+16.79%).
- SNDX annual working capital is now -4.45% below its all-time high of $522.78 million, reached on December 31, 2023.
Performance
SNDX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$499.51 M
+$144.08 M+40.54%
December 31, 2024
Summary
- As of March 5, 2025, SNDX quarterly working capital is $499.51 million, with the most recent change of +$144.08 million (+40.54%) on December 31, 2024.
- Over the past year, SNDX quarterly working capital has increased by +$144.08 million (+40.54%).
- SNDX quarterly working capital is now -4.45% below its all-time high of $522.78 million, reached on December 31, 2023.
Performance
SNDX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SNDX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.5% | +40.5% |
| 3 y3 years | +16.8% | +40.5% |
| 5 y5 years | +1036.2% | +40.5% |
SNDX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.5% | +16.8% | -4.5% | +48.3% |
| 5 y | 5-year | -4.5% | +1036.2% | -4.5% | +1036.2% |
| alltime | all time | -4.5% | +2149.8% | -4.5% | >+9999.0% |
Syndax Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $499.51 M(-4.5%) | $499.51 M(+40.5%) |
| Sep 2024 | - | $355.43 M(-11.9%) |
| Jun 2024 | - | $403.58 M(+0.1%) |
| Mar 2024 | - | $403.09 M(-22.9%) |
| Dec 2023 | $522.78 M(+13.5%) | $522.78 M(+52.9%) |
| Sep 2023 | - | $341.80 M(-9.8%) |
| Jun 2023 | - | $378.91 M(-9.3%) |
| Mar 2023 | - | $417.79 M(-9.3%) |
| Dec 2022 | $460.72 M(+7.7%) | $460.72 M(+36.8%) |
| Sep 2022 | - | $336.83 M(-6.8%) |
| Jun 2022 | - | $361.36 M(-7.2%) |
| Mar 2022 | - | $389.50 M(-8.9%) |
| Dec 2021 | $427.71 M(+52.8%) | $427.71 M(+104.1%) |
| Sep 2021 | - | $209.54 M(-12.1%) |
| Jun 2021 | - | $238.26 M(-6.3%) |
| Mar 2021 | - | $254.38 M(-9.1%) |
| Dec 2020 | $279.99 M(+536.9%) | $279.99 M(+72.5%) |
| Sep 2020 | - | $162.28 M(-9.5%) |
| Jun 2020 | - | $179.34 M(+110.0%) |
| Mar 2020 | - | $85.42 M(+94.3%) |
| Dec 2019 | $43.96 M | $43.96 M(-22.3%) |
| Sep 2019 | - | $56.56 M(-17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $68.28 M(-16.7%) |
| Mar 2019 | - | $81.97 M(+21.9%) |
| Dec 2018 | $67.24 M(-42.8%) | $67.24 M(-14.7%) |
| Sep 2018 | - | $78.83 M(-7.7%) |
| Jun 2018 | - | $85.40 M(-16.6%) |
| Mar 2018 | - | $102.40 M(-13.0%) |
| Dec 2017 | $117.64 M(+19.9%) | $117.64 M(+7.2%) |
| Sep 2017 | - | $109.76 M(-10.5%) |
| Jun 2017 | - | $122.66 M(+42.5%) |
| Mar 2017 | - | $86.07 M(-12.3%) |
| Dec 2016 | $98.14 M(+18.0%) | $98.14 M(-9.2%) |
| Sep 2016 | - | $108.12 M(-10.5%) |
| Jun 2016 | - | $120.83 M(-6.1%) |
| Mar 2016 | - | $128.73 M(+54.8%) |
| Dec 2015 | $83.16 M(+3863.8%) | $83.16 M(-5.3%) |
| Sep 2015 | - | $87.80 M(+4084.9%) |
| Dec 2014 | $2.10 M(-82.2%) | $2.10 M(-7.0%) |
| Sep 2014 | - | $2.26 M(+310.9%) |
| Jun 2014 | - | $549.00 K(-92.8%) |
| Mar 2014 | - | $7.67 M(-35.1%) |
| Dec 2013 | $11.81 M(-148.5%) | $11.81 M |
| Dec 2012 | -$24.37 M | - |
FAQ
- What is Syndax Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual working capital year-on-year change?
- What is Syndax Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly working capital year-on-year change?
What is Syndax Pharmaceuticals annual working capital?
The current annual working capital of SNDX is $499.51 M
What is the all time high annual working capital for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual working capital is $522.78 M
What is Syndax Pharmaceuticals annual working capital year-on-year change?
Over the past year, SNDX annual working capital has changed by -$23.27 M (-4.45%)
What is Syndax Pharmaceuticals quarterly working capital?
The current quarterly working capital of SNDX is $499.51 M
What is the all time high quarterly working capital for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly working capital is $522.78 M
What is Syndax Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, SNDX quarterly working capital has changed by +$144.08 M (+40.54%)